The Phase 2a study will evaluate AT7687 as a differentiated combination treatment approach for people living with obesity and type 2 diabetesA ...

Summary: Researchers have demonstrated a definitive brain-gut-bone marrow axis in mice that explains this destructive link. The data reveals that chronic psychological stress suppresses key executive ...

Multiple cohort analyses suggest MASLD correlates with incident breast cancer and worse outcomes, including signals independent of BMI, though heterogeneity in definitions and designs limits inference ...

Research by the Barcelona Institute for Biomedical Research (IIBB), part of the Spanish National Research Council (CSIC), and the Institut de Recerca Sant Pau (IR Sant Pau) provides some of the first ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Is it just me, or has it been a remarkably quiet Cowboys offseason? Almost no drama. No real turmoil. No coach on the hot seat. Yeah, sure, George Pickens wants a new deal, and he's the only guy in ...

Midi Health, the fastest growing women's telehealth company, today announced an expanded prescription skincare line built specifically for the hormonal skin changes that begin in a woman's 30s and ...

In an internal memo seen by WIRED, Bosworth promised employees more stability, better communication, and the return of workplace perks as the company seeks to improve morale. Meta did an “atrocious” ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) today announced that its Board of Directors has formally appointed Nicholas Johnson as Chief Executive Officer, effective June 1, 2026. Johnson ...

Copenhagen, Denmark, 21 May 2026 – Antag Therapeutics (“Antag” or “the Company”), advancing personalized and flexible obesity treatment through GIP receptor antagonism, today announces the appointment ...

The conversation is changing. For the first time ever, the person or thing on the other side of an interaction isn’t always human. Every time I talk with other executives, the “agentic future” comes ...